Walled Lake Planning & Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-745
Closed -$158K 114
2021
Q3
$158K Buy
745
+150
+25% +$34.5K 0.1% 88
2021
Q2
$145K Hold
595
0.09% 93
2021
Q1
$148K Buy
595
+5
+0.8% +$1.19K 0.1% 88
2020
Q4
$136K Sell
590
-8
-1% -$1.84K 0.1% 83
2020
Q3
$152K Hold
598
0.12% 76
2020
Q2
$141K Buy
598
+8
+1% +$1.82K 0.12% 74
2020
Q1
$120K Hold
590
0.11% 75
2019
Q4
$142K Buy
+590
New +$130K 0.1% 78

Other funds holding AMGN

Walled Lake Planning & Wealth Management's AMGN Position: Q4 2021 in Review

Walled Lake Planning & Wealth Management sold out of Amgen (AMGN) in Q4 2021, closing a stake of 745 shares — an estimated $158K sold.

Walled Lake Planning & Wealth Management first reported a position in AMGN in Q4 2019 and held it in 8 quarters. The position peaked at $158K in Q3 2021. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Walled Lake Planning & Wealth Management reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • Walled Lake Planning & Wealth Management sold 745 Amgen shares in Q4 2021, an estimated $158K.
  • Walled Lake Planning & Wealth Management first reported a position in Amgen in Q4 2019 and held it in 8 quarters.
  • Walled Lake Planning & Wealth Management's Amgen position peaked at $158K in Q3 2021.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Walled Lake Planning & Wealth Management's 13F filing for Q4 2021, filed 10 Feb 2022.